GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED14 April 2023
FAQs
Frequently Asked Questions
Detailed answers about HALEON UK IP LIMITED, including incorporation, status, business activity, and accounts information.
When was HALEON UK IP LIMITED founded?
HALEON UK IP LIMITED was officially incorporated on 26 September 2014 and is registered under company number 09237645. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HALEON UK IP LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HALEON UK IP LIMITED?
HALEON UK IP LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HALEON UK IP LIMITED do?
HALEON UK IP LIMITED operates in the following sector: 64209 - Activities of other holding companies n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is HALEON UK IP LIMITED's registered address?
The registered office address of HALEON UK IP LIMITED is BUILDING 5, FIRST FLOOR, THE HEIGHTS, WEYBRIDGE, SURREY, ENGLAND, KT13 0NY. This is the official address filed with Companies House for legal and statutory correspondence.
Is HALEON UK IP LIMITED financially stable?
The most recent accounts for HALEON UK IP LIMITED were made up to 31 December 2024, filed as FULL. Next accounts are due by 30 September 2026.
Has HALEON UK IP LIMITED changed its name?
Yes, HALEON UK IP LIMITED has had 1 previous name: GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED (changed 14 April 2023).